Drug profile · INN
lomustine
GLEOSTINE
lomustine (GLEOSTINE) is a dna inhibitor. Route of administration: oral. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 7
News articles 0
Drug details — lomustine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 7
- Data quality
- 0.84
Quick answer
lomustine (GLEOSTINE) is a dna inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN lomustine
Brand GLEOSTINE
Mechanism DNA inhibitor
Target DNA
Route ORAL
Formulation CAPSULE
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is lomustine?
lomustine (GLEOSTINE) is a dna inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for lomustine?
GLEOSTINE is a marketed brand name for lomustine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lomustine?
lomustine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.